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Abstract
To verify the prevalence of use, purchase and sources of iron salts and vita-
mins by children aged from 0 to 12 years in Brazil. Population-based trans-
versal study (Brazilian National Survey on Access, Utilization, and 
Promotion of Rational Use of Medicines – PNAUM), including 7,528 
children up to 12 years of age. Information was obtained through question-
naires answered by the children’s tutors, about the use of iron salts and vi-
tamins 15 days before the interview; forms of financing, and sources of ob-
tainment, sociodemographic characteristics, and presence of chronic disease. 
Descriptive and bivariate analyses were performed and the main variables 
were expressed by relative frequencies and 95% confidence intervals (95%CI). 
The prevalence of use of iron salts was 1.6% (95%CI: 1.2-2.1), with higher 
prevalence among children under 1 year old (8.5%; 95%CI: 6.3-11.5) and res-
idents of the southeastern region (2.3%; 95%CI: 1.5-3.4). Prevalence of use of 
vitamins was 4.8% (95%CI: 4.2-5.6), with higher prevalence among children 
under 1 year old (24.3%; 95%CI: 20.3-28.7) and residents of the northern re-
gion (8.6%; 95%CI: 6.2-11.7). Purchase occurred by direct reimbursement for 
41.6% (95%CI: 27.9-56.7) of the iron salts, and for 82.4% (95%CI: 76.3-87.2) 
of the vitamins. The iron salts were predominantly obtained from SUS phar-
macies (51.5%; 95%CI: 36.4-66.4), and the vitamins from commercial phar-
macies (80.6%; 95%CI: 77.4-85.6). The results suggested the use of iron salts 
in the Brazilian pediatric population was low, with reduction in use as age 
increased, regional differences and free-of-charge obtainment, predominantly 
from SUS. 
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Introduction
Anemia and other micronutrient deficiencies in children are a global public health problem. Anemia 
affects about 300 million children worldwide 1. In 2011, the highest prevalence of anemia was found 
in children under 5 years of age (42.6%; 95%CI: 33.7-47.4) 1. This condition can result in impairment 
of the following functions: growth and immunity; mental and psychomotor development, and school 
and cognitive performance. Diarrhea and respiratory infections, also resulting from anemia, contrib-
ute to increasing morbidity, in addition to overloading the health system 2.
In Brazil, the estimated prevalence of anemia in children under 5 years of age is 20.9%, according 
to the Brazilian National Survey of Demographic and Women and Child Health (PNDS, in Portuguese – 
2006 3. However, in a review performed by Vieira et al. 4 with data from studies conducted in differ-
ent epidemiological scenarios, higher prevalence values were found, ranging from 40.1% to 66.5% for 
population-based samples in populations in conditions of poverty.
World Health Organization (WHO) recommends the use of multiple micronutrient powders for 
children aged 6 months to 12 years in populations where anemia is a public health problem 5. In Bra-
zil, the Ministry of Health promotes supplementation programs to reduce the prevalence of anemia 
and nutritional deficiencies that affect the pediatric population. These programs include: NutriSUS 6, 
which involves the fortification of infant feeding through the addition of these micronutrients in the 
powdered form directly in the food available in public schools and day care centers; the Brazilian 
National Iron Supplementation Program (PNSF, in Portuguese) 7, which provides children aged 6 
months up to 24 months with ferrous sulfate, available at health facilities; and the Brazilian National 
Vitamin A Supplementation Program (PNSVA, in Portuguese) 8, which recommends the administra-
tion of megadoses of vitamin A to children aged from 6 months to 59 months, available at health units. 
According to systematic reviews conducted by The Cochrane Collaboration system, there is evidence 
in favor of iron salts 9 and vitamin A 10 supplementation. 
The Brazilian National Health Survey (PNS, in Portuguese), conducted in 2013, estimated that 
57.9% of the Brazilian children between the ages of 6 months and two years have received iron sulfate 
supplementation at some point in life 11. Studies dealing with this topic are scarce, especially those 
that have investigated aspects related to the access to these products. According to some studies, the 
use of vitamins by children between zero and 14 years varies from 4.6% to 12.6%, and the use of iron 
sulfate from 0.8% to 31% 11,12,13,14,15,16. The most recent population-based studies conducted in Bra-
zil 13,14,16 were geographically limited to a municipality or region of a state, and did not specifically 
evaluate iron salts and vitamins. 
Studies based on data related to prevalence of use, characteristics of users, most used medicines 
and forms of access to this technology will make it possible to draw a pattern of use and identify 
problems associated with access and use, contributing to the evaluation of the impact of the Ministry 
of Health programs. 
The aim of this study was to verify the prevalence of use, purchase and sources of iron salts and 
vitamins by children from zero to 12 years old in Brazil. 
Methods
Individuals aged 12 years or under comprised the population study, resident in the urban zone of 
the five Brazilian regions that participated in the Brazilian National Survey on Access, Utilization,  and 
Promotion of Rational Use of Medicines (PNAUM). PNAUM was a cross-sectional, population-based 
study with probability sampling, carried out between September 2013 and February 2014 in urban 
households at national level.
This sample could be considered similar to that of the Brazilian pediatric population when com-
pared with the age and sex data of 2010 Population Census 17. The PNAUM sampling plan provided for 
representativeness for the groups from 0 to 4 and 5 to 19 years without distinction of sex, as described 
in the methodological article of PNAUM 18. In this manuscript we did not use exactly the same age 
groups used in the sampling plan, so it was sex (50.9% boys and 49.1% girls), age (< 2 years: 13.9%, 
2-5 years: 29,0%, 6-12 years: 57,1%) and region of Brazil (North: 10.9%, Northeast: 30.7%, Southeast: 
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37.9%, South: 12.9% and Central: 6.7%) 19. Greater details about sample design, data collection logis-
tics and quality control are described in the methodological article of PNAUM 18. 
Specific questionnaires were used and answered by the main tutor of the child present in the resi-
dence at the time of the interview. At least three visits were made to each address in different shifts. 
Adults who were judged capable of reporting on the use of medicines and other supplements given to 
the children living in the household were identified as being the person responsible for them (those 
who responded on the children’s behalf). 
Information about the use of vitamins and iron salts was extracted from the question: “In the last 
15 days, did (name of the child) use any vitamin, mineral supplement, appetite stimulant or tonic?”. 
Whenever possible, the packaging or prescriptions of the medications used were presented to the 
interviewer. Data with reference to the purchase were obtained through the question: “was this 
medication paid for?”; “yes” answers were computed as payment, here considered direct reimburse-
ment; “no” answers were computed as “free-of-charge medicines”. The places where medications were 
obtained were extracted from the question “where did you obtain this medication?” and the answers 
were categorized into: retail pharmacy, Popular Pharmacy, Brazilian Unified National Health System 
(SUS) and others (charity institutions/church; free samples; friends, relatives and neighbors).  
The medicines cited by the interviewees were identified in Anvisa (Brazilian Health Regulatory 
Agency) lists of medications, and classified by the drugs contained in their composition. The iron-
containing medications were classified into: isolated iron sulfate; associated iron sulfate; other forms 
of isolated iron, and other forms of associated iron. The medications containing vitamins were classi-
fied into: ascorbic acid, folic acid, calcitriol, calcium carbonate, polyvitamins and/or minerals, retinol, 
thiamine, vitamin B, vitamin D and vitamin A and D. The products classified as vitamin supplements 
were excluded because they were not registered as medications.
The outcomes investigated were: (1) prevalence of the use of iron salts; (2) prevalence of the use 
of vitamins; (3) forms of purchase of iron salts; (4) forms of purchase of vitamins; (5) sources of iron 
salts; and (6) sources of vitamins. 
The variables analyzed were: sex (male/female), age (under 1 year, from 1 to 2 incomplete years; 
from 2 to 5 years and from 6 to 12 years); economic classification (A/B, C, D/E), in accordance with 
Brazilian Association of Research Companies (ABEP) 2013 20; region of Brazil (North, Northeast, 
Southeast, South, Central) and presence of chronic disease (yes/no). 
According to Eisenstein 21, there is no consensus about which age range covers childhood, with 
the age limit ranging from 10 to 12 years. The Food and Drug Administration (FDA) in the Guidance 
for Industry – Clinical Investigation of Medicinal Products in the Pediatric Population 22 considers the same 
age group as that used in this study, which has also been found in previous studies 13,19,23,24,25. 
The variable “presence of chronic disease” was used to verify if the use of these drugs could be dif-
ferent among healthier and less healthy children, assuming the presence of at least one chronic disease 
as an indicator of unhealthy behavior.
Descriptive and bivariate analyses were performed, and the main variables were expressed by 
relative frequencies and their respective 95% confidence intervals (95%CI). The Pearson chi-square 
test was used to evaluate the statistical significance of the differences between groups, considering 
5% level of significance. All the analyses were performed using the statistical package IBM SPSS 18.0 
(IBM Corp., Armonk, USA), and the CSPLAN set of commands appropriate for analyzing complex 
samples and guaranteeing the required ponderation according to the sample design.
The project (PNAUM) was approved by Ethics Research Committee (CONEP, report n. 398.131, 
on September 16, 2013).The participants were interviewed only after their permission had been 
obtained with the signature of both participants and researcher of the free and informed consent term.
Results
The sample effectively collected and analyzed was composed of 41,433 individuals, of whom 7,528 
were 12 years of age or younger. Of a total of 7,528 respondents, 26 did not know how to answer 
the main question (“In the last 15 days, did (name of the child) use any vitamin, mineral supplement, 
appetite stimulant or tonic?”). Table 1 presents the characteristics of the children who participated 
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Table 1 
Characteristics of children participating in PNAUM according to the use of iron salts and vitamins (n = 7,528) PNAUM, Brazil, 2014.
Characteristic % * 95%CI Iron salts (%) 95%CI p-value ** Vitamins (%) 95%CI p-value **
Age in years
0 to < 1 6.7 6.2-7.3 8.5 6.3-11.5 < 0.0001 24.3 20.3-28.7 < 0.0001
1 to < 2 6.8 6.2-7.5 5.6 4.0-7.9 12.9 10.3-15.9
2 to 5 26.9 25.2-28.6 1.2 0.8-1.7 5.6 4.4-7.1
6 to 12 59.6 57.3-61.8 0.6 0.2-1.4 1.4 0.9-2.2
Sex
Male 49.7 47.4-51.9 1.5 1.1-2.0 0.676 5.0 4.2-5.9 0.684
Female 50.3 48.1-52.6 1.7 1.1-2.5 4.7 3.9-5.8
Economic class ***
AB 16.8 14.6-19.2 1.5 0.9-2.4 0.448 5.4 4.0-7.1 0.645
C 56.2 53.4-58.9 1.8 1.2-2.6 4.9 4.0-5.9
DE 27.0 24.2-30.0 1.3 0.8-2.0 4.5 3.6-5.6
Region
North 9.9 7.4-13.3 1.4 0.9-2.4 0.004 8.6 6.2-11.7 < 0.0001
Northeast 26.7 21.4-32.7 1.2 0.8-1.9 7.0 5.6-8.7
Southeast 41.2 34.2-48.5 2.3 1.5-3.4 4.0 3.1-5.1
South 13.8 10.4-18.1 1.1 0.7-1.7 1.9 1.2-3.0
Central 8.4 6.5-10.8 0.6 0.4-1.0 2.7 1.9-3.8
Chronic disease
Yes 9.9 8.6-11.3 2.5 1.2-5.4 0.208 7.2 4.7-10.8 0.063
No 90.1 88.7-91.4 1.5 1.2-1.9 4.6 3.9-5.3
Total 1.6 1.2-2.1 4.8 4.2-5.6
95%CI: 95% confidence interval; PNAUM: Brazilian National Survey on Access, Utilization, and Promotion of Rational Use of Medicines. 
* Percentages pondered by the sample weights; 
** Pearson’s chi-squared test; 
*** In accordance with Brazilian Association of Research Companies (ABEP 2013).
in the PNAUM project and those who used iron salts and vitamins. Slightly over half (59.6%) were 
children over the age of 6 years; 50.3% were girls; and 56.2% were from class C. The larger portion 
of the children researched was concentrated (41.2%) in the Southeastern region. Approximately 10% 
presented chronic disease. 
The prevalence of the use of iron salts was 1.65% (95%CI: 1.2-2.1). Children under the age of 1 year 
showed the highest prevalence (8.5%; 95%CI: 6.3-11.5), and the children from 6 to 12 years, the low-
est level (0.6%; 95%CI: 0.2-1.4) of use. The highest level of iron salt use occurred in the Southeastern 
region. 
The prevalence of the use of vitamins was 4.8% (95%CI: 4.2-5.6). Children under the age of 1 year 
were those who made most use of this type of medication (24.3%; 95%CI: 20.3-28.7), and those living 
in the Northern region, the largest use (8.6%; 95%CI: 6.2-11.7).
Isolated iron sulfate represented over half of the iron salts used (55.4% of all the medications 
containing iron salts). Of the vitamin medication used, 45.6% were polyvitamins and minerals, 31.5% 
ascorbic acid, and 16.7% vitamin A and D (Table 2).  
The form of obtaining iron containing salts was 41.6% (95%CI: 27.9-56.7) through direct dis-
bursement, and 58.3% (95%CI: 43.1-72.0) was free of charge. When the iron salts were purchased by 
direct reimbursement, the main source was the retail pharmacy (96.6%; 95%CI: 88.7-99.0) and when 
they were obtained free of charge the main source was SUS (89.3%; 95%CI: 74.5-96.0). When ques-
tioned about from where the iron salts were obtained, SUS was mentioned in just over half of the cases 
(51.5%; 95%CI: 36.4-66.4) (Figure 1).
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Table 2 
Iron salts and vitamins used by children participating in PNAUM, Brazil, 2014.
Medication % 95%CI
Iron salts * (n = 178)
Isolated ferrous sulfate 55.4 43.5-66.7
Other forms of isolated iron 28.2 19.9-38.3
Associated ferrous sulfate 12.6 5.1-28.0
Other forms of associated iron 3.9 1.9-7.8
Total 100 -
Vitamins (n = 718) 
Polyvitamins and minerals ** 45.6 39.1-52.2
Ascorbic acid 31.5 26.4-37.1
Vitamins A and D 16.7 11.6-23.4
Folic acid 2.0 0.7-6.0
Vitamin D 1.9 0.8-4.5
Calcitriol 1.0 0.1-6.8
Retinol 0.5 0.2-1.2
Calcium carbonate 0.4 0.1-2.7
Thiamine 0.3 0.0-2.1
Vitamin B 0.1 0.1-0.4
Total 100 -
95%CI: 95% confidence interval; PNAUM: Brazilian National Survey on Access, Utilization, and Promotion of Rational Use of 
Medicines. 
* Classification of medications containing iron: isolated ferrous sulfate, associated ferrous sulfate (for example: ferrous 
sulfate/phosphoric acid, ferrous sulfate/phosphoric acid/aromatic and therapeutic tonic plant extracts), other forms of 
isolated iron (for example: ferric polymaltose, iron amino acid chelates, iron glycinate), and other forms of associated 
iron (for example: chelated iron/folic acid/cyanocobalamin; ferric polymaltose/folic acid; iron amino acid chelates/folic 
acid; iron glycinate/folic acid); 
** Classification of medications such as polyvitamins and minerals – examples: ascorbic acid/pyridoxine/ thiamine;  
buclizine/caffeine/lysine/nicotinamide/thiamine; cholecalciferol/ascorbic acid; ascorbic acid/pyridoxine/thiamine.
The form of obtaining vitamins was divided into purchase by direct reimbursement (82.4%; 
95%CI: 76.3-87.2); free of charge (17.1%; 95%CI: 12.3-23.2) and the source data missing was ignored 
(0.5%; 95%CI: 0.1-1.9). When the vitamins were purchased by direct reimbursement, the main source 
was the retail pharmacy (97.5%; 95%CI: 95.0-98.8) and when they were obtained free of charge the 
main source was SUS (88.9%; 95%CI: 75.5-95.4). When the interviewees were asked from where they 
obtained the vitamins, the predominant answer was commercial pharmacies (80.6%; 95%CI: 74.4-
85.6) (Figure 1). 
Table 3 presents the financing by direct reimbursement according to region and economic clas-
sification. Purchase of iron salts by direct reimbursement occurred most frequently in the Northern 
region, and purchase of vitamins, in the northeastern region. The purchase of both iron salts and vita-
mins occurred more frequently in the economic classes A/B. Despite presenting differences between 
regions and economic classes in relation to the point estimates of prevalence, we observed that only 
the use of vitamins in comparison with the regions was statistically significant.
Discussion
The results of this study showed that the use of iron salts by the Brazilian pediatric population was 
low, and lower than the consumption of vitamins. The use of iron salts was lower in older children. 
The highest level of iron salt use occurred in the Southeastern region, and of vitamins, in the Northern 
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Figure 1
Forms of purchase and sources of iron salts and vitamins PNAUM, Brazil, 2014.
Other: charity institution/church, free samples, friends, relatives or neighbors; PNAUM: Brazilian National Survey on Access, Utilization, and Promotion of 
Rational Use of Medicine.
region. Most iron salts were obtained free of charge, whereas the larger portions of vitamins were 
purchased by direct reimbursement.
The prevalence of 1.6% of the use of iron salts was similar to the one found in previous studies, 
such as those by Béria et al. 12 (1.7%), with children up to 4 years of age in Pelotas, Rio Grande do 
Sul State, Brazil; and by Santos et al. 15 (2%), with children from 4 to 11 years old in Salvador, Bahia 
State Brazil. Nevertheless, other population-based studies conducted in Brazil pointed out higher 
prevalence values: 11.5% 13, with children under 14 years in the Jequitinhonha Valley, Minas Gerais 
State, Brazil; 11.1% 16 with children aged 1 to 5 years in Vitória, Espírito Santo State, Brazil; 31.5% in 
PNDS 2006 26; and 57.9% in PNS 2013 11. Comparison with the results of these studies must consider 
that the studies with higher prevalence values used considerably longer periods of records (the last 
6 months in PNDS 26 and at some point in life in PNS 11) than other studies using the same period 
of time as PNAUM (15 days prior to the interview) 13,15. Other methodological aspects, such as the 
format of the question the interviewee was asked (medication-directed or not), in addition to the chil-
dren’s characteristics, such as age and health conditions, may explain the differences in the prevalence 
values found in the studies 11,13,16,26. In spite of the importance of using iron salts to prevent anemia 9, 
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Table 3 
Financing by direct reimbursement of iron salts and vitamins, by geographic region and economic classification  
according to PNAUM, Brazil, 2014.
Iron salts Vitamins
% 95%CI % 95%CI
Region p = 0.299 p = 0.007
North 73.7 40.5-92.0 85.0 72.9-92.3
Northeast 50.9 35.2-66.4 93.8 84.2-97.7
Southeast 32.8 15.0-57.4 68.5 54.2-79.9
South 42.3 20.9-67.0 77.4 53.7-91.0
Central 46.9 22.5-72.9 88.4 76.7-94.7
ABEP p = 0.684 p = 0.720
A/B 56.7 29.5-80.4 86.6 69.0-94.9
C 39.4 21.4-60.8 82.7 75.0-88.4
D/E 38.1 20.9-58.8 78.4 64.3-88.0
Total 41.6 27.9-56.7 82.4 76.3-87.2
95%CI: 95% confidence interval; ABEP: Brazilian Association of Research Companies; PNAUM: Brazilian National Survey on 
Access, Utilization, and Promotion of Rational Use of Medicines.
the consumption may be considered low in all the age ranges analyzed in the PNAUM survey. Even 
among younger children (< 2 years) the consumption of iron salts was low, due to the recommenda-
tion by PNSF of prophylactic use in all children between the ages of six months and two years. 
If we compare the prevalence of the use of iron salts in this study with data from health inquiries 
conducted in Europe, such as those by Du et al. 23, conducted in Germany; and Carrasco et al. 24, in 
Spain, we would verify similar prevalence values (1.1% and 3.4%, respectively). However, the preva-
lence values of anemia in these countries were lower than those in Brazil, according to WHO  data 1. 
In the USA, where the prevalence of iron deficiency affected 8 to 14% of the children, according to the 
Slone Study, the use of iron salts among children from 0 to 11 years in the 7 days prior to the interview 
was 9.7%, a situation that may be related to the high consumption of vitamin and mineral supplements 
by American children 25. The fact that those responsible for the children did not recognize iron sulfate 
as a form of preventing anemia, in addition to the lack of knowledge about the consequences of ane-
mia and difficulties with adhesion, resulting from the adverse effects, may be factors that complicated 
the use of this medication 16,27,28.
The prevalence of the use of vitamins (4.8%) was close to the values found in other studies, ranging 
from 4.6% to 11.5% 12,13,15,16,23. The higher prevalence in the use of vitamins in comparison with iron 
salts may be associated with the sale condition of some vitamins, which do not require prescriptions 
and are considered safe by the population 29; or because people do not consider vitamins to be medi-
cines and use them to complement a poor diet. 
The prevalence values of iron salts and vitamins found were lower in older children. This datum is 
in agreement with the prevalence of anemia that was shown to be higher in children under the age of 
5 years 30 and with the recommendation by PNSF of prophylactic use up to 2 years of age. Particularly 
between the ages of six months and two years, the need for this mineral increases due to the children’s 
rapid growth 31. Other studies also observed a low prevalence of anemia in older children 26,32,33. The 
use of iron salts presented a higher prevalence in children from the Southeastern region, and lower 
prevalence in the population from the Central region, in agreement with the prevalence of anemia in 
these regions, pointed out by PNDS 2006 (higher prevalence in the Northeastern [25.5%], Southeast-
ern [22.6%] and Southern [21.5%] regions; and lower prevalence in the Northern [10.4%] and Central 
[11%] regions) 26. PNS 2013 also found higher consumption of iron sulfate by children of 6 months up 
to 2 years of age 11 in the Southeastern region, in comparison with the other regions. The differences 
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in the prevalence of use of iron salts among regions could also be associated with other factors, such 
as differences in coverage of health services and in the operationalization of PNSF.
The use of vitamins was greater in the Northern and Northeastern regions and lower in the 
Southern region. These differences may be explained, at least partially, by the potential use of vita-
mins in self-medication; and data of PNAUM itself pointed out reasons for the higher prevalence of 
self-medication in these two regions 34. Furthermore, data from PNDS have shown that the Northern 
region has the highest rates of weight-age and weight-height deficit for children under the age of 5 
years in comparison with the other regions. This may be linked to the high level of use of vitamins by 
children from the Southern region 3.
Iron sulfate was the iron salt used in little over half of the cases. Iron sulfate is provided free of 
charge by SUS through PNSF, and, until the end of 2015, it could be acquired by co-payment in the 
Brazilian Popular Pharmacy services of the network itself, favoring a higher level of its use in com-
parison with more expensive isolated irons (iron amino acid chelates and ferric polymaltose), accord-
ing to the Anvisa 35 bulletin. The systematic review conducted by De-Regil et al. 9 found that iron 
sulfate does not present hematological outcome results different from those presented by the other 
forms of iron. Moreover, ferrous salts present high frequency of up to 40% adverse effects including: 
pyrosis, epigastralgia, nausea, vomiting, metallic taste, darkening of the teeth, dyspepsia, abdominal 
discomfort, diarrhea, and constipation. The symptoms are dose-related and tend to disappear in 2 to 
3 days after the onset of treatment. Due to the frequency and intensity of adverse effects of iron salts, 
they have lower tolerance, worse adhesion to therapy, and thus worse results in comparison with fer-
ric polymaltose 36,37.
Among the vitamins, the polyvitamins, ascorbic acid and vitamin A+D were those most used, in 
agreement with previous studies 12,13. Data from PNAUM published in 2016 revealed that ascorbic 
acid was ranked the fifth most used medication among children 19. Ascorbic acid is possibly being 
used to improve the absorption of iron, or to prevent influenza and colds, although this latter use is 
not backed by evidence 38.
Direct reimbursement for purchasing of iron salts occurred with higher frequency than was 
expected, considering that iron sulfate is present in the Brazilian National List of Essential Medicines 
(RENAME, in Portuguese) and in PNSF. The presence of iron sulfate is consistent with systematic 
reviews that demonstrate similar efficacy 9 and tolerability 39 to other forms of iron. On the one hand, 
the option not to use the services offered by SUS, and on the other hand, lack, irregularity and/or 
unavailability of medication supplies in the public health services, may lead to a significant portion of 
the population buying the medications with their own resources.
Differently from the iron salts, vitamins were predominantly purchased by direct reimbursement 
(88.9%) from the retail pharmacy. These findings are in agreement with data from the Brazilian House-
hold Budget Surveys (PNAD, in Portuguese) 2008-2009, which demonstrated that vitamins represented 
the fifth group of medications on which Brazilian families spent their budget 40. A factor that con-
tributed to the lower access to vitamins obtained free of charge is the reduced number of this class of 
drugs available in the list of the basic component of pharmaceutical care. On the other hand, many 
of the vitamins used by children consist of polyvitamins and minerals, some in combinations and 
amounts that are not justified by evidence, and whose use and availability are not stated in RENAME.
In this study, we did not collect data about diagnosis of anemia and other micronutrient deficien-
cies in the children, which prevented these conditions from being related to the therapeutic use of 
iron salts and vitamins. Despite the size and characteristics of the sample (7,528 children aged 0 to 12 
residing in municipalities of different sizes from the 5 regions of the country, including all capitals), 
we cannot affirm that the sample was representative of the entire Brazilian pediatric population due 
to the following factors: differences in the coverage network, income level and education of parents/
tutors, cultural differences and access to medicines, age differences used for this study (0 to 12 years) 
in relation to the sampling plan for representativeness (0 to 4 years and 5 to 19 years) used in the 
PNAUM, among other factors. Finally, specific questions about feeding received at day care centers 
and schools, and about administration of megadoses of vitamin A to children at health services were 
not included in the questionnaire, to enable the PNSVA and NutriSUS to be assessed to some extent. 
However, measures of iron salts were adequate to assess the scope of the PNSF in the five regions of 
the country.
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In conclusion, the use of iron salts by the Brazilian pediatric population was low, and lower than 
the consumption of vitamins, which suggested that the PNSF still needs to attain part of the popula-
tion that would be within the recommended criteria for use. The use of iron salts and vitamins was 
lower in older children, in accordance with this stage of development in which the need for iron salts 
and vitamins is reduced. The higher level of use of iron salts occurred in the Southeastern region. 
Most iron salts were obtained free of charge, because they were made available by SUS and their use 
was recommended by PNSF, which should have contributed to a higher consumption than the value 
found. The majority of vitamins, in turn, were purchased by direct reimbursement. These data should 
be combined with future qualitative methodologies that involve other aspects of access policies and 
perception on use of iron salts and vitamins by parents/tutors.
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Resumo
O estudo teve como objetivo verificar a preva-
lência do uso, aquisição e fontes de saís de ferro 
e vitaminas para crianças entre 0 e 12 anos de 
idade no Brasil. Foi realizado um estudo trans-
versal de base populacional (Pesquisa Nacional 
sobre Acesso, Utilização e Promoção do Uso 
Racional de Medicamentos – PNAUM), in-
cluindo 7.528 crianças até 12 anos de idade. As 
informações foram obtidas através de questioná-
rios respondidos pelos pais ou responsáveis, so-
bre o uso de sais de ferro e vitaminas nos 15 dias 
anteriores à entrevista; formas de financiamento 
e fontes de aquisição, características sociodemo-
gráficas e presença de doenças crônicas. Foram 
realizadas análises descritivas e bivariadas, e as 
principais variáveis foram expressas como fre-
quências relativas com intervalos de 95% de con-
fiança (IC95%). A prevalência do uso de sais de 
ferros foi 1,6% (IC95%: 1,2-2,1), com prevalência 
maior entre crianças com menos de 1 ano de ida-
de (8,5%; IC95%: 6,3-11,5) e residentes da Região 
Sudeste (2,3%; IC95%: 1,5-3,4). A prevalência do 
uso de vitaminas foi 4,8% (IC95%: 4,2-5,6), com 
prevalência maior entre crianças com menos de 1 
ano (24,3%;IC95%: 20,3-28,7) e residentes da Re-
gião Norte (8,6%; IC95%: 6,2-11,7). A aquisição 
ocorreu por reembolso direto em 41,6% (IC95%: 
27,9-56,7) dos sais de ferro e em 82,4% (IC95%: 
76,3-87,2) das vitaminas. Os sais de ferro foram 
adquiridos predominantemente através das far-
mácias do SUS (51,5%; IC95%: 36,4-66,4), e as vi-
taminas em farmácias comerciais (80,6%; IC95%: 
77,4-85,6). Os resultados sugerem que o uso de sais 
de ferro na população pediátrica brasileira é por 
baixo, com uma redução no uso conforme aumen-
ta a idade da criança, além de diferenças regionais 
e aquisição gratuita, predominantemente do SUS. 
Pré-Escolar; Sais de Ferro; Vitaminas; Uso de 
Medicamentos; Fatores Socioeconômicos
Resumo
Este trabajo tiene el fin de verificar la prevalen-
cia de uso, adquisición y fuentes de sales de hierro 
y vitaminas por parte de niños desde 0 a 12 años 
de edad en Brasil. Se trata de un estudio trans-
versal, basado en población (Encuesta Nacional 
sobre el Acceso, Uso y Promoción de Uso 
Racional de Medicinas – PNAUM por sus si-
glas en portugués), que incluye a 7.528 niños de 
hasta 12 años de edad. La información se obtuvo 
a través de cuestionarios respondidos por los tu-
tores de los niños, sobre el uso de sales de hierro 
y vitaminas 15 días antes de la entrevista; for-
mas de financiación, y fuentes de adquisición, 
características sociodemográficas, y presencia de 
alguna enfermedad crónica. Se realizaron análi-
sis descriptivos y bivariados, además las variables 
principales se plasmaron mediante frecuencias re-
lativas e intervalos del 95% de confianza (IC95%). 
La prevalencia del uso de sales de hierro fue de un 
1,6% (IC95%: 1,2-2,1), con una prevalencia más 
alta entre niños por debajo de un 1 año de edad 
(8,5%; IC95%: 6,3-11,5) y residentes de la Región 
sudeste (2,3%; IC95%: 1,5-3,4). La prevalencia del 
uso de vitaminas fue de un 4,8% (IC95%: 4,2-5,6), 
con una prevalencia más alta con niños menores 
de 1 año de edad (24,3%; IC95%: 20,3-28,7) y re-
sidentes de la Región nordeste (8,6%; IC95%: 6,2-
11,7). La adquisición tuvo lugar por reembolso 
directo en un 41,6% (IC95%: 27,9-56,7) de sales 
de hierro, y por un 82,4% (IC95%: 76,3-87,2) de 
las vitaminas. Las sales de hierro se obtuvieron 
predominantemente en farmacias del SUS (51,5%; 
IC95%: 36,4-66,4), y las vitaminas en farmacias 
comerciales (80,6%; IC95%: 77,4-85,6). Los resul-
tados sugirieron el consumo de las sales de hierro 
en la población pediátrica brasileña fue por bajo, 
con una reducción en su consumo a medida que 
la edad aumentaba, además de diferencias regio-
nales, y su obtención gratuita, predominantemente 
del SUS. 
Preescolar; Sales de Hierro; Vitaminas; Utiliza-
ción de Medicamentos; Factores Socioeconómicos
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